Brian S. Koll, MD Recently retired as Executive Medical Director for Infection Prevention and Control, Mount Sinai Health
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers identify new protein in a common subtype of breast cancer which can potentially offer more effective therapies for the future.
Denise Cai, PhD, Assistant Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai, has been selected as one of the Allen Institute for Brain Science's 2017 Next Generation Leaders.
In a large population study that was the first of its kind, researchers found that a simple tool not requiring laboratory tests, the Fuster-BEWAT score, is as effective as the American Heart Association-recommended ICHS (Ideal Cardiovascular Health Index), which includes blood analysis of cholesterol and glucose.
New Practice Kicks Off Innovative Oral Health Program
MuleSoft, an application network company, announced Mount Sinai, New York’s largest integrated health system is leveraging Anypoint Platform to broaden its ability to share data beyond the four walls of its hospitals. Historically, Mount...Show More Summary
Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Microfinance institutions are found effective in delivering essential health products to underserved communities on a national scale while reducing costs.
The Tisch Cancer Institute and the Precision Immunology Institute at Mount Sinai Health System are part of a $215 million public-private Cancer Moonshot research collaboration launched by the National Institutes of Health and 11 leading pharmaceutical companies.
New research from The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai, suggests that the capabilities of microfinance networks expand well beyond banking, and that tapping into these networks can bring measurable health improvements to rural and underserved communities on a national scale with reduced cost.
Mount Sinai Health System, New York City’s largest integrated delivery system has signed an agreement with Lumeris, a value-based care management service provider to optimize Mount Sinai’s population health outcomes. Mount Sinai hasShow More Summary
Erick Eiting, MD Assistant Professor, Emergency Medicine Icahn School of Medicine at Mount Sinai Director of Emergency Medicine
R. Sean Morrison, MD, has been appointed the Ellen and Howard C. Katz Chair of the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS).
One of 13 physicians appointed as a member of the Society of Honorary Police Surgeons of the City of New York
Three faculty members from the Icahn School of Medicine at Mount Sinai have been elected to the National Academy of Medicine (NAM).
The National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR) has awarded the Icahn School of Medicine at Mount Sinai's Department of Rehabilitation Medicine and the Brain Injury Research Center a five-year grant totaling $2.2 million to fund the New York Traumatic Brain Injury Model System at Mount Sinai to study traumatic brain injury (TBI).
Diane E. Meier, MD, director of the Center to Advance Palliative Care (CAPC) and professor of geriatrics and palliative care medicine at the Icahn School of Medicine at Mount Sinai, has been named the 32nd recipient of the Gustav O. Lienhard Award for Advancement in Healthcare, announced today by the National Academy of Medicine.
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies. Show More Summary
Accurately subtyping glioblastoma tumors could lead to diagnostics and precision therapy